Vancomycin mimicry: towards new supramolecular antibiotics

Area of Science:

• Microbiology
• Medicinal Chemistry
• Pharmacology

Background:

• Vancomycin, a key glycopeptide antibiotic (GPA), inhibits bacterial cell wall synthesis by targeting the D-Ala-D-Ala epitope.
• This target is evolutionarily conserved, contributing to vancomycin's long-standing efficacy and limited resistance development over 60 years.

Purpose of the Study:

• To review vancomycin's structure and mechanism of action.
• To survey historical efforts in developing vancomycin mimics.
• To advocate for future research into novel vancomycin-inspired agents.

Main Methods:

• Literature review of vancomycin's biochemical properties.
• Analysis of past synthetic and medicinal chemistry approaches to vancomycin mimicry.
• Synthesis of arguments for continued development of GPA analogs.

Main Results:

• Vancomycin's established efficacy stems from its specific binding to the D-Ala-D-Ala target.
• Limited resistance has emerged due to the target's crucial role in bacterial viability.
• Past mimicry efforts have faced challenges in synthesis and modification.

Conclusions:

• Vancomycin remains a critical antibiotic, but resistance necessitates new therapeutic strategies.
• Developing simplified, modifiable vancomycin mimics offers a promising avenue to expand GPA utility.
• Renewed focus on vancomycin mimicry research is essential for addressing antibiotic resistance.